Cargando…

Repurposing of host-based therapeutic agents for the treatment of coronavirus disease 2019 (COVID-19): a link between antiviral and anticancer mechanisms?

Detalles Bibliográficos
Autores principales:	Alonso, Daniel F., Farina, Hernán G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd and International Society of Antimicrobial Chemotherapy. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391054/ https://www.ncbi.nlm.nih.gov/pubmed/32739476 http://dx.doi.org/10.1016/j.ijantimicag.2020.106125

Ejemplares similares

Repurposing old drugs as antiviral agents for coronaviruses
por: Yang, Cheng-Wei, et al.
Publicado: (2020)

Repurposing Tranexamic Acid as an Anticancer Agent
por: Law, Mary E., et al.
Publicado: (2022)

Repurposing host-based therapeutics to control coronavirus and influenza virus
por: Li, Cui-Cui, et al.
Publicado: (2019)

Repurposing Antifungals for Host-Directed Antiviral Therapy?
por: Schloer, Sebastian, et al.
Publicado: (2022)

Repurposing dyphylline as a pan-coronavirus antiviral therapy
por: Wang, Yining, et al.
Publicado: (2022)

Penfluridol as a Candidate of Drug Repurposing for Anticancer Agent
por: Tuan, Nguyen Minh, et al.
Publicado: (2019)

Anticancer activity of repurposed hemostatic agent desmopressin on AVPR2-expressing human osteosarcoma
por: Sobol, Natasha Tatiana, et al.
Publicado: (2021)

Repurposing the serotonin agonist Tegaserod as an anticancer agent in melanoma: molecular mechanisms and clinical implications
por: Liu, Wei, et al.
Publicado: (2020)

Perspectives for repurposing drugs for the coronavirus disease 2019
por: Cherian, Sarah S., et al.
Publicado: (2020)

Drug repurposing against COVID-19: focus on anticancer agents
por: Ciliberto, Gennaro, et al.
Publicado: (2020)

Repurposing of cyclophilin A inhibitors as broad-spectrum antiviral agents
por: Han, Jinhe, et al.
Publicado: (2022)

Repurposing carrimycin as an antiviral agent against human coronaviruses, including the currently pandemic SARS-CoV-2
por: Yan, Haiyan, et al.
Publicado: (2021)

Topological network based drug repurposing for coronavirus 2019
por: Habibi, Mahnaz, et al.
Publicado: (2021)

Ethacrynic Acid: A Promising Candidate for Drug Repurposing as an Anticancer Agent
por: Yu, Lu, et al.
Publicado: (2023)

Repurposing Molnupiravir for COVID-19: The Mechanisms of Antiviral Activity
por: Yip, Ashley Jia Wen, et al.
Publicado: (2022)

Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model
por: Fan, Hua-Hao, et al.
Publicado: (2020)

Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents
por: Kannappan, Vinodh, et al.
Publicado: (2021)

A Review of Treatment of Coronavirus Disease 2019 (COVID-19): Therapeutic Repurposing and Unmet Clinical Needs
por: Chen, Po-Lin, et al.
Publicado: (2020)

Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review
por: Rodrigo, C., et al.
Publicado: (2020)

Pulmonary delivery of nanostructured lipid carriers for effective repurposing of salinomycin as an antiviral agent
por: Pindiprolu, Sai Kiran S.S., et al.
Publicado: (2020)

Repurposing Tamoxifen as Potential Host-Directed Therapeutic for Tuberculosis
por: Boland, Ralf, et al.
Publicado: (2022)

Elucidating host cell response pathways and repurposing therapeutics for SARS-CoV-2 and other coronaviruses
por: Shen, Zhewei, et al.
Publicado: (2022)

A Panel of Broad-Spectrum Antivirals in Topical Ophthalmic Medications from the Drug Repurposing Approach during and after the Coronavirus Disease 2019 Era
por: Napoli, Pietro Emanuele, et al.
Publicado: (2020)

Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents
por: Ananthula, Hari Krishna, et al.
Publicado: (2018)

Antiviral Treatment of Coronavirus Disease-2019 Pneumonia
por: Radcliffe, Christopher, et al.
Publicado: (2023)

Therapeutic Targeting of Repurposed Anticancer Drugs in Alzheimer’s Disease: Using the Multiomics Approach
por: Advani, Dia, et al.
Publicado: (2021)

Statins as candidate therapeutic agents for coronavirus disease 2019 (COVID-19)
por: Li, Sheng-De, et al.
Publicado: (2021)

Repurposing the anticancer drug cisplatin with the aim of developing novel Pseudomonas aeruginosa infection control agents
por: Yuan, Mingjun, et al.
Publicado: (2018)

Drug repurposing of dermatologic medications to treat coronavirus disease 2019: Science or fiction?
por: Vassileva, Snejina, et al.
Publicado: (2021)

Drug repurposing against coronavirus disease 2019 (COVID-19): A review
por: Luo, Lianxiang, et al.
Publicado: (2021)

Repurposing drugs to fast-track therapeutic agents for the treatment of cryptococcosis
por: Truong, Megan, et al.
Publicado: (2018)

Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system
por: Punekar, Madhura, et al.
Publicado: (2022)

Metal and Metal Oxides Nanoparticles and Nanosystems in Anticancer and Antiviral Theragnostic Agents
por: Shabatina, Tatyana I., et al.
Publicado: (2023)

Structure–Activity Relationships of Triphenylethylene Derivatives and Their Evaluation as Anticancer and Antiviral Agents
por: Ahmed, Nermin S., et al.
Publicado: (2023)

Recent progress of antiviral therapy for coronavirus disease 2019
por: Zhao, Mengmeng, et al.
Publicado: (2021)

The wisdom of crowds and the repurposing of artesunate as an anticancer drug
por: Augustin, Yolanda, et al.
Publicado: (2015)

Anticancer Properties of Fenofibrate: A Repurposing Use
por: Lian, Xin, et al.
Publicado: (2018)

Repurposing anticancer drugs for the management of COVID-19
por: El Bairi, Khalid, et al.
Publicado: (2020)

Fruit fly for anticancer drug discovery and repurposing
por: Nainu, Firzan, et al.
Publicado: (2023)

Therapeutic potential of coumarins as antiviral agents
por: Hassan, Mohd. Zaheen, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hcj5qkqidncg3d93u7io6a1fl0